• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种变体对年轻男性和老年女性严重新冠病毒疾病结局的保护作用

Protective Role of a Variant on Severe COVID-19 Outcome in Young Males and Elderly Women.

作者信息

Monticelli Maria, Hay Mele Bruno, Benetti Elisa, Fallerini Chiara, Baldassarri Margherita, Furini Simone, Frullanti Elisa, Mari Francesca, Andreotti Giuseppina, Cubellis Maria Vittoria, Renieri Alessandra

机构信息

Department of Biology, Università Federico II, 80126 Napoli, Italy.

Integrative Marine Ecology Department, Stazione Zoologica Anton Dohrn, Villa Comunale, 80121 Napoli, Italy.

出版信息

Genes (Basel). 2021 Apr 19;12(4):596. doi: 10.3390/genes12040596.

DOI:10.3390/genes12040596
PMID:33921689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8073081/
Abstract

The protease encoded by the gene facilitates viral infections and has been implicated in the pathogenesis of SARS-CoV-2. We analyzed the sequence and correlated the protein variants with the clinical features of a cohort of 1177 patients affected by COVID-19 in Italy. Nine relatively common variants (allele frequency > 0.01) and six missense variants which may affect the protease activity according to PolyPhen-2 in HumVar-trained mode were identified. Among them, p.V197M (p.Val197Met) (rs12329760) emerges as a common variant that has a deleterious effect on the protease and a protective effect on the patients. Its role appears particularly relevant in two subgroups of patients-young males and elderly women-and among those affected by co-morbidities, where the variant frequency is higher among individuals who were mildly affected by the disease and did not need hospitalization or oxygen therapy than among those more severely affected, who required oxygen therapy, ventilation or intubation. This study provides useful information for the identification of patients at risk of developing a severe form of COVID-19, and encourages the usage of drugs affecting the expression of or inhibiting protein activity.

摘要

该基因编码的蛋白酶促进病毒感染,并与SARS-CoV-2的发病机制有关。我们分析了该序列,并将蛋白质变体与意大利1177名新冠肺炎患者队列的临床特征相关联。鉴定出九个相对常见的变体(等位基因频率>0.01)和六个错义变体,根据HumVar训练模式下的PolyPhen-2,这些变体可能影响蛋白酶活性。其中,p.V197M(p.Val197Met)(rs12329760)是一种常见变体,对蛋白酶有有害影响,对患者有保护作用。其作用在两个患者亚组——年轻男性和老年女性——以及合并症患者中显得尤为重要,在疾病轻度受影响且无需住院或吸氧治疗的个体中,该变体频率高于那些受影响更严重、需要吸氧治疗、通气或插管的个体。本研究为识别有发展为重症新冠肺炎风险的患者提供了有用信息,并鼓励使用影响该基因表达或抑制蛋白质活性的药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e5/8073081/2d51ca9059e4/genes-12-00596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e5/8073081/2d51ca9059e4/genes-12-00596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e5/8073081/2d51ca9059e4/genes-12-00596-g001.jpg

相似文献

1
Protective Role of a Variant on Severe COVID-19 Outcome in Young Males and Elderly Women.一种变体对年轻男性和老年女性严重新冠病毒疾病结局的保护作用
Genes (Basel). 2021 Apr 19;12(4):596. doi: 10.3390/genes12040596.
2
Regional TMPRSS2 V197M Allele Frequencies Are Correlated with COVID-19 Case Fatality Rates.区域 TMPRSS2 V197M 等位基因频率与 COVID-19 病死率相关。
Mol Cells. 2021 Sep 30;44(9):680-687. doi: 10.14348/molcells.2021.2249.
3
A common TMPRSS2 variant has a protective effect against severe COVID-19.一种常见的 TMPRSS2 变体对严重 COVID-19 具有保护作用。
Curr Res Transl Med. 2022 May;70(2):103333. doi: 10.1016/j.retram.2022.103333. Epub 2022 Jan 10.
4
In silico evidence that substitution of glycine for valine (p.G8V) in a common variant of TMPRSS2 isoform 1 increases accessibility to an endocytic signal: Implication for SARS-cov-2 entry into host cells and susceptibility to COVID-19.在 TMPRSS2 同工型 1 的常见变体中,甘氨酸取代缬氨酸(p.G8V)的计算证据增加了进入内吞信号的易感性:对 SARS-CoV-2 进入宿主细胞和 COVID-19 易感性的影响。
Biochimie. 2024 Oct;225:89-98. doi: 10.1016/j.biochi.2024.05.004. Epub 2024 May 14.
5
Assessment of risk conferred by coding and regulatory variations of and in susceptibility to SARS-CoV-2 infection in human.评估人类中ACE2和TMPRSS2的编码及调控变异在SARS-CoV-2感染易感性方面所带来的风险。
J Genet. 2020;99(1). doi: 10.1007/s12041-020-01217-7.
6
Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.新冠病毒感染患者 TMPRSS2 p.Val160Met 基因变异的初步研究。
Hum Genomics. 2021 May 17;15(1):29. doi: 10.1186/s40246-021-00330-7.
7
Computational Analysis of Missense Variants in the Human Transmembrane Protease Serine 2 () and SARS-CoV-2.人类跨膜丝氨酸蛋白酶 2 () 中错义变异的计算分析与 SARS-CoV-2
Biomed Res Int. 2021 Oct 19;2021:9982729. doi: 10.1155/2021/9982729. eCollection 2021.
8
TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population.TMPRSS2 多态性(rs12329760)与伊朗人群中 COVID-19 的严重程度。
PLoS One. 2023 Feb 16;18(2):e0281750. doi: 10.1371/journal.pone.0281750. eCollection 2023.
9
Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS-CoV-2 from 946 whole-exome sequencing data in the Turkish population.分析 ACE2 和 TMPRSS2 编码变异作为土耳其人群 946 例全外显子测序数据中 SARS-CoV-2 的风险因素。
J Med Virol. 2022 Nov;94(11):5225-5243. doi: 10.1002/jmv.27976. Epub 2022 Jul 22.
10
Association of TMPRSS2 Gene Polymorphisms with COVID-19 Severity and Mortality: a Case-Control Study with Computational Analyses.TMPRSS2 基因多态性与 COVID-19 严重程度和死亡率的关联:一项病例对照研究及计算分析。
Appl Biochem Biotechnol. 2022 Aug;194(8):3507-3526. doi: 10.1007/s12010-022-03885-w. Epub 2022 Apr 7.

引用本文的文献

1
The Possible Mechanistic Basis of Individual Susceptibility to Spike Protein Injury.个体对刺突蛋白损伤易感性的可能机制基础。
Adv Virol. 2025 Jun 24;2025:7990876. doi: 10.1155/av/7990876. eCollection 2025.
2
Host genetics and COVID-19 severity: increasing the accuracy of latest severity scores by Boolean quantum features.宿主遗传学与新冠病毒疾病严重程度:利用布尔量子特征提高最新严重程度评分的准确性。
Front Genet. 2024 May 22;15:1362469. doi: 10.3389/fgene.2024.1362469. eCollection 2024.
3
The fatal contribution of serine protease-related genetic variants to COVID-19 outcomes.

本文引用的文献

1
Regional TMPRSS2 V197M Allele Frequencies Are Correlated with COVID-19 Case Fatality Rates.区域 TMPRSS2 V197M 等位基因频率与 COVID-19 病死率相关。
Mol Cells. 2021 Sep 30;44(9):680-687. doi: 10.14348/molcells.2021.2249.
2
Common variants at 21q22.3 locus influence and gene expression and susceptibility to severe COVID-19.21号染色体长臂22.3区域的常见变异影响基因表达及对重症COVID-19的易感性。
iScience. 2021 Apr 23;24(4):102322. doi: 10.1016/j.isci.2021.102322. Epub 2021 Mar 17.
3
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
丝氨酸蛋白酶相关遗传变异对 COVID-19 结局的致命影响。
Front Immunol. 2024 Mar 27;15:1335963. doi: 10.3389/fimmu.2024.1335963. eCollection 2024.
4
Association between genetic polymorphism, severity, and treatment response among COVID-19 infected Egyptian patients.新型冠状病毒肺炎感染的埃及患者的基因多态性、严重程度与治疗反应之间的关联
Front Pharmacol. 2023 Jun 22;14:1209286. doi: 10.3389/fphar.2023.1209286. eCollection 2023.
5
Impacts of SARS-CoV-2 on diabetes mellitus: A pre and post pandemic evaluation.严重急性呼吸综合征冠状病毒2对糖尿病的影响:大流行前后评估
World J Virol. 2023 Jun 25;12(3):151-171. doi: 10.5501/wjv.v12.i3.151.
6
Genetic Variants within SARS-CoV-2 Human Receptor Genes May Contribute to Variable Disease Outcomes in Different Ethnicities.SARS-CoV-2 人类受体基因内的遗传变异可能导致不同种族的疾病结局存在差异。
Int J Mol Sci. 2023 May 13;24(10):8711. doi: 10.3390/ijms24108711.
7
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance.新冠病毒相关急性呼吸窘迫综合征的细胞和分子特征:治疗意义
J Inflamm (Lond). 2023 Mar 20;20(1):11. doi: 10.1186/s12950-023-00333-2.
8
TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population.TMPRSS2 多态性(rs12329760)与伊朗人群中 COVID-19 的严重程度。
PLoS One. 2023 Feb 16;18(2):e0281750. doi: 10.1371/journal.pone.0281750. eCollection 2023.
9
Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population.乌克兰人群中,tmprss2(rs12329760)多态性而非 ace2(rs4240157)、tmprss11a(rs353163)和 cd147(rs8259)与 COVID-19 的严重程度相关。
Acta Biomed. 2023 Feb 13;94(1):e2023030. doi: 10.23750/abm.v94i1.13543.
10
Polymorphisms in , , , , and Genes Are Associated with Worse Clinical Outcomes in COVID-19.基因、、、和中的多态性与 COVID-19 的临床结局恶化相关。
Genes (Basel). 2022 Dec 22;14(1):29. doi: 10.3390/genes14010029.
甲磺酸卡莫司他通过 TMPRSS2 相关蛋白酶抑制 SARS-CoV-2 的激活,其代谢产物 GBPA 发挥抗病毒活性。
EBioMedicine. 2021 Mar;65:103255. doi: 10.1016/j.ebiom.2021.103255. Epub 2021 Mar 4.
4
and variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19.基因变异是新冠病毒感染结果的潜在预测指标:是时候实施针对新冠肺炎的精准医学了。
Heliyon. 2021 Feb;7(2):e06133. doi: 10.1016/j.heliyon.2021.e06133. Epub 2021 Jan 28.
5
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research.采用系统方法进行生物银行建设,并分析临床和遗传数据,以推进 COVID-19 研究。
Eur J Hum Genet. 2021 May;29(5):745-759. doi: 10.1038/s41431-020-00793-7. Epub 2021 Jan 17.
6
Nafamostat mesylate-induced hyperkalemia in critically ill patients with COVID-19: Four case reports.甲磺酸那法莫司他致新型冠状病毒肺炎危重症患者高钾血症:4例病例报告
World J Clin Cases. 2020 Nov 6;8(21):5320-5325. doi: 10.12998/wjcc.v8.i21.5320.
7
Evidence for treatment with estradiol for women with SARS-CoV-2 infection.有证据表明,对于感染 SARS-CoV-2 的女性,用雌二醇进行治疗。
BMC Med. 2020 Nov 25;18(1):369. doi: 10.1186/s12916-020-01851-z.
8
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone.雄激素剥夺疗法与SARS-CoV-2感染:睾酮的潜在双面作用
Ther Adv Endocrinol Metab. 2020 Oct 31;11:2042018820969019. doi: 10.1177/2042018820969019. eCollection 2020.
9
Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.甲磺酸卡莫司他治疗 SARS-CoV-2 和 COVID-19 的作用机制、剂量和安全性。
Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):204-212. doi: 10.1111/bcpt.13533. Epub 2020 Nov 22.
10
COVID19 Drug Repository: text-mining the literature in search of putative COVID19 therapeutics.COVID19 药物库:从文献中挖掘文本以寻找潜在的 COVID19 疗法。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1113-D1121. doi: 10.1093/nar/gkaa969.